OBJECTIVE: b b-adrenergic receptors (b bARs) play an important role in the regulation of energy expenditure and lipid mobilization. A Gl-27Glu polymorphism in the b b 2 -adrenergic receptor (b b 2 AR) gene has recently been associated with several indices of obesity in a female Caucasian population, while the same polymorphism exhibited no association with obesity in another, albeit male, population. METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the b b 2 AR with BMI, plasma leptin and UCP-1 mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women. RESULTS: The frequencies of the Gln27 and the Gly16 alleles as well as the b b 2 AR haplotypes were similar in our morbidly obese and lean subjects. Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma leptin or adipose tissue UCP-1 gene expression in either group. CONCLUSIONS: We conclude that the two polymorphisms in the b b 2 AR gene studied are not a major factor contributing to obesity in our population.
Introduction
Catecholamines play an important role in energy expenditure. Genes involved in the regulation of catecholamine function may therefore be of particular importance for human obesity. The three known bARs are expressed in human adipocytes and mediate lipid mobilization in vivo. 1 bARs may also be implicated in adaptive thermogenesis, as they stimulate uncoupling protein (UCP)-1 gene expression in immortalized brown adipose cell lines. 2 Recently, two con¯icting reports appeared on the association of a common Gln27Glu polymorphism in the b 2 AR with human obesity. Because the Glu27 b 2 AR variant shows aberrant biochemical activities in vitro compared to the wild-type receptor, it is a likely candidate to have impact on human obesity. Large et al, studied 140 Swedish women displaying a large variation in body fat mass and found a signi®cantly higher frequency of homozygous carriers of the Glu27 allele in women with a body mass index (BMI) b 27 kgam 2 than in those with a BMI`27 kgam 2 . 3 In contrast, a study in 156 juvenile obese Danish men and 205 male controls representing a population-based sample showed no such association. 4 Swedish and Danish populations are thought to be genetically similar and should therefore exhibit similar associations, but the Danish study was conducted in men, while the Swedish study was conducted in women. Hence, the association of the Glu27 allele with obesity that was observed in the Swedish study may re¯ect an interaction of the polymorphism with female gender. To test this hypothesis, we studied the associations of the Gln27Glu and the Gly16Arg polymorphisms in the b 2 AR gene with obesity in another population of Caucasian women. We furthermore investigated possible associations of these polymorphisms with BMI, plasma leptin and UCP-1 mRNA expression in intraperitoneal adipose tissue in obese women.
Methods
Our study population consisted of 183 unrelated, obese women who were consecutively referred for weight reducing surgery through gastric banding. 216 unrelated lean female health care workers served as control. The average BMI of obese women was 42.8 AE 6.6 kgam 2 (range 28.3 ± 81.8). The BMI was b 35 in 93 and b 40 in 63% of the obese women. The average BMI of control women was 22.0AE 2.6 kgam 2 (range 16.9 ± 29.7). Average age was 36.4 AE 10.6 and 33.3 AE 13.9 y for obese and control women, respectively (P`0.02). Plasma leptin was measured with a RIA kit (Linco Inc., St Charles, MO). In a subset of obese subjects, UCP-1 mRNA abundance was measured by competitive reverse transcription (RT)-polymerase-chain reaction (PCR) in intraperitoneal adipose tissue specimens obtained during weight reducing surgery as described. 5 Genomic DNA was isolated from peripheral leukocytes and adipose tissue specimens using the QIAamp Blood and Tissue Kits, respectively (Qiagen Inc., Hilden, Germany). Average intra-and extraperitoneal fat cell size was estimated from the DNA content per adipose tissue weight in a subset of 75 obese subjects. The Gln27Glu and Gly16Arg polymorphisms in the b 2 AR gene were determined by restriction enzyme isotyping of PCR products as described by Martinez et al. 6 Study subjects gave informed consent and the study was approved by the institutional review board.
Results and Discussion
The b 2 AR genotyping results are shown in Table 1 . Using w 2 -tests (3Â2 tables, 2 d.f.) no association was found between either of the two b 2 AR polymorphisms and obesity. The estimated frequencies of the Gln27 allele were 0.659 and 0.620 in our obese and lean subjects, respectively, while the corresponding frequencies of the Gly16 allele were 0.571 and 0.597. These frequencies are very similar to the values observed in Danish obese and non-obese men and to those in the Caucasian children studied by Martinez et al. 6 Unlike in the study of Large et al, 3 the observed genotype frequencies of the two polymorphisms were in agreement with Hardy ± Weinberg expectations in both obese and lean subjects (w 2 for Gln27Glu or Gly16Arg were 0.594 or l.008 in obese and 0.688 or 0.073 in lean women). Since the Argl6, but not the Glu27 substitution was associated with altered b 2 AR function in vivo as well as in vitro, 3, 7 we considered the relationship of b 2 AR haplotypes with obesity. Haplotypes were constructed with maximum likelihood methods. 8 According to these analyses, more than 95% of the Argl6 substitutions were present on Gln27 alleles in both obese and lean women and standardized linkage disequilibrium statistics showed highly signi®cant disequilibrium coef®cients of 0.904 and 0.888 in obese and lean subjects, respectively (both P`0.000l), but haplotype frequencies were not signi®cantly different between obese and lean subjects ( Table 1) .
Numerous genetic and environmental factors may have contributed to obesity in our population. We therefore compared, among obese women, various obesity indices that could have been discriminatory for carriers of the Glu27 allele. Using ANOVA, no signi®cant differences among the Gln27Glu genotypes were observed in age-adjusted values for BMI (P 0.950), plasma leptin (P 0.225), and intraand extraperitoneal fat cell-size (P 0.945 and 0.582). Similarly, no signi®cant differences were noted among the Gln-27Glu genotypes when the median values of these indices were compared using the Kruskal ± Wallis test (not shown). We have previously reported that intraperitoneal adipose tissue expression of UCP1 mRNA was signi®cantly lower in obese subjects than in controls. 5 Since signaling through b 2 ARs may in¯uence UCP-1 mRNA expression 2 , we compared the relation of UCP-1 mRNA expression levels with Gln27Glu genotypes in obese women. UCP-1 mRNA abundance levels in 54 Gln27Gln, 65 Gln27Glu and 16 Glu27Glu subjects were 2.8 AE 4.7, 3.4 AE 2.0 and 2.9 AE 1.7 amolafmol bactin, respectively (P 0.206, ANOVA adjusted for age).
Since our study participants were not ascertained in a random population-based manner, differences or similarities in allele frequencies between the two groups could have resulted from differences in ascertainment. However, the fact that allele frequencies in both our groups were similar to those previously observed in a population-based sample, argue against a major bias in ascertainment. Further studies in other populations are required to de®ne the role of mutations in the b 2 AR in human obesity. In summary, the Gln27Glu and the Gly16Arg polymorphisms in the b 2 AR gene are not associated with morbid obesity in our sample of obese Austrian women. 
